NLS Pharmaceutics OverviewNLS Pharmaceutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for NLSP.
Quarterly EBIT
-$2.22M
↓ 13.93% YoY
As of Jun 30, 2025
Annual EBIT (TTM)
-$10.01M
↑ 53.81% YoY
Trailing 12 months ending Jun 30, 2025
NLS Pharmaceutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for NLSP.
As of Jun 30, 2025
Trailing 12 months ending Jun 30, 2025